Sustained reduction in confirmed disability progression in patients with primary progressive multiple sclerosis treated with ocrelizumab in the open-label extension period of the Phase III ORATORIO trial

被引：0

作者：

Wolisnky, J. S. ^{[1
]}

Brochet, B. ^{[2
]}

Montalban, X. ^{[3
,4
]}

Naismith, R. T. ^{[5
]}

Manfrini, M. ^{[6
]}

Garas, M. ^{[6
]}

Villoslada, P. ^{[7
]}

Model, F. ^{[6
]}

Hubeaux, S. ^{[6
]}

Kappos, L. ^{[8
]}

Hauser, S. L. ^{[9
]}

机构：

[1] UTHealth, McGovern Med Sch, Houston, TX USA

[2] Univ Bordeaux, Bordeaux, France

[3] Univ Toronto, Div Neurol, Toronto, ON, Canada

[4] Vall dHebron Univ Hosp, Barcelona, Spain

[5] Washington Univ, Sch Med, St Louis, MO USA

[6] F Hoffmann La Roche Ltd, Basel, Switzerland

[7] Genentech Inc, San Francisco, CA 94080 USA

[8] Univ Basel, Univ Hosp Basel, Basel, Switzerland

[9] Univ Calif San Francisco, San Francisco, CA 94143 USA

来源：

MULTIPLE SCLEROSIS JOURNAL | 2018年 / 24卷

基金：

新加坡国家研究基金会;

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P910

引用

页码：490 / 491

页数：2

共 50 条

[41] Aspirin, Warfarin, or Enoxaparin Thromboprophylaxis in Patients With Multiple Myeloma Treated With Thalidomide: A Phase III, Open-Label, Randomized Trial
Palumbo, Antonio
Cavo, Michele
Bringhen, Sara
Zamagni, Elena
Romano, Alessandra
Patriarca, Francesca
Rossi, Davide
Gentilini, Fabiana
Crippa, Claudia
Galli, Monica
Nozzoli, Chiara
Ria, Roberto
Marasca, Roberto
Montefusco, Vittorio
Baldini, Luca
Elice, Francesca
Callea, Vincenzo
Pulini, Stefano
Carella, Angelo M.
Zambello, Renato
Benevolo, Giulia
Magarotto, Valeria
Tacchetti, Paola
Pescosta, Norbert
Cellini, Claudia
Polloni, Claudia
Evangelista, Andrea
Caravita, Tommaso
Morabito, Fortunato
Offidani, Massimo
Tosi, Patrizia
Boccadoro, Mario
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (08) : 986 - 993
[42] Neural stem cell transplantation in patients with progressive multiple sclerosis: an open-label, phase 1 study
Genchi, Angela
Brambilla, Elena
Sangalli, Francesca
Radaelli, Marta
Bacigaluppi, Marco
Furlan, Roberto
Andolfo, Annapaola
Drago, Denise
Magagnotti, Cinzia
Scotti, Giulia Maria
Greco, Raffaella
Vezzulli, Paolo
Ottoboni, Linda
Bonopane, Marco
Capilupo, Daniela
Ruffini, Francesca
Belotti, Daniela
Cabiati, Benedetta
Cesana, Stefania
Matera, Giada
Leocani, Letizia
Martinelli, Vittorio
Moiola, Lucia
Vago, Luca
Panina-Bordignon, Paola
Falini, Andrea
Ciceri, Fabio
Uglietti, Anna
Sormani, Maria Pia
Comi, Giancarlo
Battaglia, Mario Alberto
Rocca, Maria A. A.
Storelli, Loredana
Pagani, Elisabetta
Gaipa, Giuseppe
Martino, Gianvito
NATURE MEDICINE, 2023, 29 (01) : 75 - +
[43] Neural stem cell transplantation in patients with progressive multiple sclerosis: an open-label, phase 1 study
Angela Genchi
Elena Brambilla
Francesca Sangalli
Marta Radaelli
Marco Bacigaluppi
Roberto Furlan
Annapaola Andolfo
Denise Drago
Cinzia Magagnotti
Giulia Maria Scotti
Raffaella Greco
Paolo Vezzulli
Linda Ottoboni
Marco Bonopane
Daniela Capilupo
Francesca Ruffini
Daniela Belotti
Benedetta Cabiati
Stefania Cesana
Giada Matera
Letizia Leocani
Vittorio Martinelli
Lucia Moiola
Luca Vago
Paola Panina-Bordignon
Andrea Falini
Fabio Ciceri
Anna Uglietti
Maria Pia Sormani
Giancarlo Comi
Mario Alberto Battaglia
Maria A. Rocca
Loredana Storelli
Elisabetta Pagani
Giuseppe Gaipa
Gianvito Martino
Nature Medicine, 2023, 29 : 75 - 85
[44] Safety patterns with ozanimod in phase 3 and open-label extension trials in patients with relapsing multiple sclerosis
Selmaj, K. W.
Ziemssen, T.
Comi, G.
Hartung, H. P.
Singal, M.
Thorpe, A.
Riolo, J. V.
Cheng, C. Y.
Sheffield, J. K.
Krakovich, A.
Vermersch, P.
Cree, B. A. C.
EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 324 - 324
[45] An open-label, long-term, phase III extension trial of duloxetine in Japanese patients with fibromyalgia
Murakami, Masato
Osada, Kenichi
Ichibayashi, Hisao
Mizuno, Hiromichi
Ochiai, Toshimitsu
Ishida, Mitsuhiro
Alev, Levent
Nishioka, Kusuki
MODERN RHEUMATOLOGY, 2017, 27 (04) : 688 - 695
[46] Long-term reduction of relapse rate and confirmed disability progression after 6 years of ocrelizumab treatment in patients with relapsing multiple sclerosis
Giovannoni, G.
Kappos, L.
Hauser, S. L.
Montalban, X.
Koendgen, H.
Prajapati, K.
Manfrini, M.
Mehta, L.
Wolinsky, J. S.
MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 537 - 538
[47] Long-term reduction of relapse rate and confirmed disability progression after 6 years of ocrelizumab treatment in patients with relapsing multiple sclerosis
Giovannoni, G.
Kappos, L.
Hauser, S. L.
Montalban, X.
Koendgen, H.
Prajapati, K.
Manfrini, M.
Mehta, L.
Wolinsky, J.
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 405
[48] Long-term reduction of relapse rate and confirmed disability progression after 5 years of ocrelizumab treatment in patients with relapsing multiple sclerosis
Hauser, S. L.
Brochet, B.
Montalban, X.
Naismith, R. T.
Wolinsky, J. S.
Manfrini, M.
Garas, M.
Villoslada, P.
Model, F.
Hubeaux, S.
Kappos, L.
MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 285 - 286
[49] ABATACEPT TREATMENT FOR PATIENTS WITH EARLY ACTIVE PRIMARY SJOGREN'S SYNDROME: OPEN-LABEL EXTENSION PHASE OF A RANDOMIZED CONTROLLED PHASE III TRIAL
Arends, S.
Van Nimwegen, J. F.
Mossel, E.
Van Zuiden, G. S.
Delli, K.
Stel, A. J.
Van der Vegt, B.
Haacke, E. A.
Olie, L.
Los, L.
Verstappen, G. M.
Pringle, S. A.
Spijkervet, F. K. L.
Kroese, F. G. M.
Vissink, A.
Bootsma, H.
ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 102 - 102
[50] Infusion-related reactions in the Phase III double-blind, placebo-controlled ORATORIO study of ocrelizumab in primary progressive multiple sclerosis (PPMS)
Montalban, X.
Arnold, D.
Bar-or, A.
de Seze, J.
Giovannoni, G.
Hemmer, B.
Rammohan, K.
Mairon, N.
Chin, P.
Fontoura, P.
Garren, H.
Masterman, D.
Sauter, A.
Wolinsky, J.
EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 : 410 - 410

← 1 2 3 4 5 →